Kazakhstan has been approved for an on-site assessment mission and an observed inspection in 2027 as part of its application for membership of the Pharmaceutical Inspection Co-operation Scheme (PIC/S). The decision was made at a PIC/S meeting in Istanbul on 2–3 November 2026, attended by inspectors from the National Centre for Expertise of Medicines and Medical Devices under the Ministry of Healthcare of Kazakhstan. The on-site mission will be the next stage in the assessment of Kazakhstan’s pharmaceutical inspectorate. PIC/S experts are expected to examine how the national inspectorate operates...